Doctor Image

Dr. Narendra Agrawal

MBBS, MD, DM (Clinical Hematology- AIIMS)


Sr. Consultant – Hemato Oncology & Bone Marrow Transplant

Book an Appointment

RGCIRC, Rohini, Delhi - 110 085

About

Dr. Narendra Agrawal is a highly skilled Clinical Hematologist with extensive experience in the diagnosis and treatment of blood disorders. He earned his DM in Clinical Hematology from the prestigious All India Institute of Medical Sciences (AIIMS), Delhi, in 2011. His journey in hematology began in 2007 with training at SGPGIMS, Lucknow, followed by AIIMS, Delhi. Since January 2012, he has been serving as a Consultant at RGCIRC, where he specializes in treating patients with blood cancers, anemia, thalassemia, and bleeding disorders. Beyond his clinical expertise, Dr. Agrawal is deeply involved in academic activities, postgraduate teaching, and research. His contributions to the field include numerous scientific publications in esteemed national and international journals, as well as presentations at international forums. Additionally, he plays a key role in training and education at RGCIRC, serving as a coordinator and tutor for the PICC Training Program and the Bone Marrow Biopsy Training Program.

Specialized Areas

  • Allogeneic bone marrow/ stem cell transplantation
  • Haplo-identical bone marrow/ stem cell transplantation
  • Autologous bone marrow/ stem cell transplantation
  • Blood cancers like acute leukemia (AML, ALL), lymphoma, myeloma, myelodysplastic syndromes
  • Blood diseases like anemia, aplastic anemia, bleeding disorders (eg ITP), coagulation disorder (eg DVT)
  • Congenital blood disorders like Thalassemia and other hemoglobinopathies, Hemophilia

Educational Background

  • D.M. (Hematology), All India Institute of Medical Sciences, Delhi
  • M.D, Jawahar Lal Nehru Medical College, Ajmer, Rajasthan (University of Rajasthan)
  • M.B.B.S, Ravindra Nath Tagore Medical College, Udaipur, Rajasthan (University of Rajasthan)

Experience

  • Consultant, RGCIRC, Delhi: 2012 – till date
  • Research and clinical trials in such areas as AML, DVT, ALL, BMT, Lymphoma and Myeloma, ITP
  • Teaching experience in clinical hematology, 2007
  • Experience in hematology and bone marrow transplantation, 2007
  • Clinical experience, 2000

Professional Journey

PUBLICATION

Publications: His main area of research and publications has been acute lymphoblastic leukemia (ALL) and Multiple Myeloma. From a large list of his research publications, few notable publications are

  • Kapoor J, Agrawal N, Ahmed R, Sharma SK, Gupta A, Bhurani D. Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study. Mediterr J Hematol Infect Dis. 2015 Feb 20;7(1): e2015013. doi: 10.4084/MJHID.2015.013.
  • Agrawal N, Aggarwal M, Kapoor J, Ahmed R, Shrestha A, Kaushik M, Bhurani D. Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation. Transplant Infectious Disease. 2018 Feb;20(1): e12794.
  • Aggarwal M, Agrawal N, Yadav N, Verma P, Ahmed R, Mehta P, Kapoor J, Bhurani D. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma. Annals of Hematology. 2018 May 21:1-9.
  • Agrawal N, Verma P, Yadav N, Ahmed R, Mehta P, Soni P, Francis S, Bhurani D. Outcome of Philadelphia Positive Acute Lymphoblastic LeukemiaWith or Without Allogeneic Stem Cell Transplantation in a Retrospective Study. Indian J Hematol Blood Transfus. 2019 Apr 12;35(2):240-7.
  • Agrawal N, Yadav N, Verma P, Soni P, Mehta P, Thekkudan SF, Ahmed R, Bhurani D. Study of Haploidentical Stem Cell Transplantation for Philadelphia/BCR-ABL Positive Acute Lymphoblastic Leukemia. Indian J Hematol Blood Transfus. 2019 Apr 12;35(2):357-9.
  • Kapoor J, Pramanik SK, Agrawal P, Khushoo V, Naim F, Mirgh SP, Ahmed R, Bhurani D, Agrawal N. Retrospective institutional analysis of fludarabine/8 Gy TBI reduced intensity conditioning in high risk ALL. Bone Marrow Transplantation. 2020 Apr 14:1-3
  • Vivek Radhakrishnan, Narendra Agrawal, Bhausaheb Bagal, Ishan Patel; Systematic Review of the Burden and Treatment Patterns of Adult and Adolescent Acute Lymphoblastic Leukemia in India: Comprehending the Challenges in an Emerging Economy. Clinical Lymphoma, Myeloma and Leukemia (2020), doi: https://doi.org/10.1016/j.clml.2020.08.023
  • Tribikram Panda, Sujay Rainchwar, Reema Singh, Aakanksha Singh, Mayank Soni, Disha Kakkar, KR Jegan, Reshmi Harikumar Pillai, Roy J.Palatty, Karuna Jha, Rayaz Ahmed, Rohan Halder, Narender Tejwani, Devasis Panda, Dinesh Bhurani, Narendra Agrawal, Real World Outcome of B ALL with t (1; 19) (q23; p13)/TCF3::PBX1 in Adolescents and Adults Treated with Intensive Regimes. Leukemia ResearchVolume 141, June 2024, 107506. https://doi.org/10.1016/j.leukres.2024.107506

Opportunity to Help

DONATE FOR CANCER CARE

As a society, RGCIRC is looking forward to get support from generous people

Read More
DONATE BLOOD

It is a fact that there are absolutely no substitutes to replace human bloo...

Read More
DONATE TIME (VOLUNTEER)

Volunteers play an important role in today’s hospitals. They help the hos...

Read More

Rajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.

D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222
OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday)
Emergency Services: 24x7 All weekdays

Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200
OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday)
Emergency Services: 24x7 All Weekdays

Subscribe Today For Our Healthy Tips Newsletter
Loading